extracorporeal photopheresis for the treatment of ctcl
Published 3 years ago • 386 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:12
reviewing the use of extracorporeal photopheresis in treating ctcl
-
2:59
ecp for cutaneous lymphoma: current landscape & first prospective trial
-
1:04
ecp immunomodulation for cutaneous lymphoma: current & future perspectives
-
1:39
updates on the phase i trial of rocbrutinib (lp-168), a novel btki, for the treatment of cll
-
0:53
evolution of the treatment landscape for patients with cns lymphoma
-
1:11
the value of combining acalabrutinib with chemoimmunotherapy in patients with r/r dlbcl
-
0:53
the potential future role of combination therapies with btk inhibitors for mantle cell lymphoma
-
11:40
what is cutaneous t cell lymphoma?
-
21:38
drawing the line: the rationale behind blood tube collection order
-
5:53
immunohistochemistry (ihc) - video protocol series
-
1:29
managing waldenström's in 2024: optimizing the btki backbone & moving towards fixed-duration therapy
-
1:10
an update on novel treatments for mcl
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:30
the future of photopheresis for the treatment of cutaneous t-cell lymphoma
-
0:51
analysis of infiltrating cells in the tumor microenvironment
-
1:12
an update in cellular therapies: gene editing for scd and immunotherapies for mm
-
3:22
the use of photopheresis for the treatment of cutaneous t-cell lymphoma
-
6:03
photopheresis: cancer treatment goes beyond skin deep
-
1:18
the role of cellular immunotherapies in the future treatment of hl
-
1:34
the role of the immune microenvironment in ptld
-
2:05
novel therapies on the horizon for cutaneous t-cell lymphoma
-
1:05
where do bispecific antibodies fit into the large cell lymphoma treatment landscape?